Skip to main content
. 2013 Jan 12;20(5):1714–1721. doi: 10.1245/s10434-012-2841-1

Fig. 1.

Fig. 1

Local recurrence rates (including relapses after generalized metastases) (a) and survival rates (b) for patients with clinically enlarged regional lymph node metastases who had either gamma-guided or classical therapeutic lymph node dissection (TLND). The estimated local failure- and survival rates for all 77 patients with palpable metastases were 25 and 39 %, respectively